Astellas, Sony announce research collaboration for ADC platform in oncology
Astellas Pharma and Sony Corporation have signed an agreement for a research collaboration to discover a novel Antibody-Drug Conjugate (ADC) platform in oncology. Under the collaboration, Astellas and